Immunovant ($IMVT) Insider Trading & Smart Money Activity
Immunovant, Inc. ($IMVT) has 16 insider trades, 2 13F position changes and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 7 insiders sold ($2.82M), net -$2.82M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 7
- Net insider $ (12 mo)
- -$2.82M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 1
IMVT insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 4 · $2.36M | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 1 · $103.48K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 4 · $356.10K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All IMVT insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Open-market sale) | 1.33K sh | $42.54K | -12.9% | — | |||||
| Insider | Stout Jay SChief Technology Officer | Sell (Open-market sale) | 3.81K sh | $122.12K | -12.9% | — | |||||
| Insider | Gloria MelanieChief Operating Officer | Sell (Open-market sale) | 2.24K sh | $71.85K | -12.9% | — | |||||
| Insider | Venker EricChief Executive Officer | Sell (Open-market sale) | 3.51K sh | $119.59K | -9.4% | — | |||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Open-market sale) | 2.85K sh | $103.48K | -2.2% | — | |||||
| Analyst | Citigroup | Reiterates to buy | PT $61 | +4.0% | +2.5% | Read | |||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Option exercise) | 17.82K sh | -0.6% | +3.2% | — | |||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Buy (Option exercise) | 17.82K sh | $270.92K | -0.6% | +3.2% | — | ||||
| Insider | Jay StoutChief Technology Officer | Sell (Open-market sale) | 40K sh | $1.53M | -0.6% | +3.2% | — | ||||
| Insider | Atul Pande | Sell (Open-market sale) 10b5-1 | 1.50K sh | $57.02K | -0.6% | +3.2% | — | ||||
| Insider | Atul Pande | Buy (Option exercise) | 1.50K sh | $12.64K | -0.6% | +3.2% | — | ||||
| Insider | Melanie GloriaChief Operating Officer | Sell (Open-market sale) | 17.71K sh | $678.60K | -0.6% | +3.2% | — | ||||
| Insider | Tiago GiraoChief Financial Officer | Sell (Option exercise) | 10K sh | -0.6% | +3.2% | — | |||||
| Insider | Tiago GiraoChief Financial Officer | Buy (Option exercise) | 10K sh | $159K | -0.6% | +3.2% | — | ||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Open-market sale) | 2.63K sh | $93.22K | +8.2% | +13.0% | Read | ||||
| Insider | Atul Pande | Sell (Option exercise) | 1.50K sh | +13.9% | +19.3% | — | |||||
| Insider | Atul Pande | Buy (Option exercise) | 1.50K sh | $12.64K | +13.9% | +19.3% | — | ||||
| 13F | Farallon Capital Management | Added | +1.53M sh | $51.98M | +24.2% | +21.6% | — | ||||
| 13F | Farallon Capital Management | Added | +1.53M sh | $59.57M | +24.2% | +21.6% | Read |
1W / 1M / 6M = how IMVT moved from the trade or filing date.
Insider trading in IMVT: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Van Tuyl Christopher | Chief Legal Officer | 5 | -$239.24K | Oct 7, 2026 | |
| Stout Jay S | Chief Technology Officer | 1 | -$122.12K | Oct 7, 2026 | |
| Gloria Melanie | Chief Operating Officer | 1 | -$71.85K | Oct 7, 2026 | |
| Venker Eric | Chief Executive Officer | 1 | -$119.59K | Oct 2, 2026 | |
| Atul Pande | 4 | -$57.02K | Jun 26, 2026 | ||
| Tiago Girao | Chief Financial Officer | 2 | — | Jun 26, 2026 | |
| Jay Stout | Chief Technology Officer | 1 | -$1.53M | Jun 26, 2026 | |
| Melanie Gloria | Chief Operating Officer | 1 | -$678.60K | Jun 26, 2026 |
Institutions moving IMVT (13F)
Analyst ratings on IMVT
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Citigroup | Reiterates | buy | $61 | +4.0% | +2.5% | Read |
Frequently asked questions
Are IMVT insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 7 insiders made 9 open-market sales worth $2.82M, a net -$2.82M.
What is the latest insider trade in IMVT?
Van Tuyl Christopher, Chief Legal Officer filed a sell (open-market sale) of 1.33K sh worth $42.54K on Oct 7, 2026.
Which institutions changed their IMVT positions?
Recent 13F filers moving the stock include Farallon Capital Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.
SMS Terms
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.